Navigation

P21

Poster
Bile Acids as Novel Vascular Signalling Molecules and Therapeutic Target

E. Osto1, A. Jomard1, P. Doytcheva1, O. Chavez-Talavera2, A. Tailleux2, B. Staels2, A. von Eckardstein1, C. Wolfrum3, F. Ruschitzka4, T. Lutz4 (1Schlieren-Zurich ; 2Lille FR; 3Schwerzenbach ; 4Zurich)


Background: Bariatric surgery (RYGB) reduces cardiovascular mortality and improves HDL mediated vasoprotection. Bile acids (BA) are emerging as signaling molecules controlling cardio-metabolic health. Plasmatic BA circulate partly bound to HDL. Purpose: we tested whether and how changes in composition of BA bound to HDL (HDL-BA) after RYGB contribute to HDL-mediated endothelial protection. Methods: HDL isolated from 47 obese patients before and 1 year after RYGB were tested for their protective properties using human endothelial cell in vitro. HDL BA and lipid composition was quantified by liquid chromatography-mass spectrometry (LC/MS). Results: 1 year after RYGB, higher concentrations (up to 25%) of BA were bound to HDL with an increase  on HDL of BA agonists either for nuclear FXR, e.g. cholic acid (CA) and chenodeoxy-CA (CDCA), or for membrane receptor TGR5, e.g. taurolitho-CA (TLCA). After RYGB, HDL levels were increased and HDL-mediated endothelial NO production, anti-apoptotic and cholesterol efflux capacity were restored. The composition-function analysis showed that higher HDL-CA correlated with improved anti-apoptotic capacity. Further, RYGB improves the lipidomic profile of HDL with reduced cholesteryl esters and toxic ceramides, and increased anti-oxidant plasmalogens.

Conclusions: RYGB increases the concentration and improves the function and the molecular lipid composition of HDL. Interestingly, higher concentrations of BA bound to HDL after RYGB may mediate HDL’s improved endothelial-protective effects via enhanced endothelial activation of FXR and TGR5.

    
        Array
(
    [id] => 14
    [abstract_id] => 50
    [session_id] => 1
    [pres_nbr] => P21
    [updated] => 
    [created] => 0000-00-00 00:00:00
    [abstract] => Array
        (
            [id] => 50
            [user_id] => 28
            [contact_id] => 29
            [knr] => 80e01112
            [titel] => Bile Acids as Novel Vascular Signalling Molecules and Therapeutic Target

            [text] => 

Background: Bariatric surgery (RYGB) reduces cardiovascular mortality and improves HDL mediated vasoprotection. Bile acids (BA) are emerging as signaling molecules controlling cardio-metabolic health. Plasmatic BA circulate partly bound to HDL. Purpose: we tested whether and how changes in composition of BA bound to HDL (HDL-BA) after RYGB contribute to HDL-mediated endothelial protection. Methods: HDL isolated from 47 obese patients before and 1 year after RYGB were tested for their protective properties using human endothelial cell in vitro. HDL BA and lipid composition was quantified by liquid chromatography-mass spectrometry (LC/MS). Results: 1 year after RYGB, higher concentrations (up to 25%) of BA were bound to HDL with an increase  on HDL of BA agonists either for nuclear FXR, e.g. cholic acid (CA) and chenodeoxy-CA (CDCA), or for membrane receptor TGR5, e.g. taurolitho-CA (TLCA). After RYGB, HDL levels were increased and HDL-mediated endothelial NO production, anti-apoptotic and cholesterol efflux capacity were restored. The composition-function analysis showed that higher HDL-CA correlated with improved anti-apoptotic capacity. Further, RYGB improves the lipidomic profile of HDL with reduced cholesteryl esters and toxic ceramides, and increased anti-oxidant plasmalogens.

Conclusions: RYGB increases the concentration and improves the function and the molecular lipid composition of HDL. Interestingly, higher concentrations of BA bound to HDL after RYGB may mediate HDL’s improved endothelial-protective effects via enhanced endothelial activation of FXR and TGR5.

[pres_form] => [bio_presenting_author] => [german_presentation] => 0 [contact_complete] => 1 [authors_complete] => 1 [abstract_complete] => 1 [images_complete] => 1 [confirmation_complete] => 1 [updated] => [created] => 2019-03-01 22:16:01 [sprache] => en [atherosclerosis_basic] => 0 [atherosclerosis_clinical] => 0 [heartfailure_basic] => 0 [heartfailure_clinical] => 0 [arrhythmia_basic] => 0 [arrhythmia_clinical] => 0 [hypertension_diabetes_dyslipidemia] => 1 [preventive_medicine] => 0 [contact] => stdClass Object ( [id] => 29 [user_id] => 28 [anrede] => 2 [akad_titel] => 4 [vorname] => Elena [name] => Osto [institution] => University of Zurich and University Hospital Zurich [department] => Institute of Clinical Chemistry [adresszeile1] => Wagistrasse 14 [adresszeile2] => [adresszeile3] => [plz] => 8952 [ort] => Schlieren-Zurich [land] => CH [email] => elena.osto@uzh.ch [telefon] => [lang] => [updated] => [created] => 0000-00-00 00:00:00 ) [authors] => Array ( [0] => stdClass Object ( [id] => 120 [abstract_id] => 50 [vorname] => Elena [name] => Osto [qualification] => [institution] => University of Zurich and Heart Center-University Hospital Zurich [ort] => Schlieren-Zurich [land] => [sort] => 10 [is_presenting_author] => [updated] => [created] => 0000-00-00 00:00:00 ) [1] => stdClass Object ( [id] => 121 [abstract_id] => 50 [vorname] => Anne [name] => Jomard [qualification] => [institution] => University of Zurich and University Hospital Zurich [ort] => Schlieren-Zurich [land] => [sort] => 1 [is_presenting_author] => [updated] => [created] => 0000-00-00 00:00:00 ) [2] => stdClass Object ( [id] => 122 [abstract_id] => 50 [vorname] => Petia [name] => Doytcheva [qualification] => [institution] => University of Zurich and University Hospital Zurich [ort] => Schlieren-Zurich [land] => [sort] => 3 [is_presenting_author] => [updated] => [created] => 0000-00-00 00:00:00 ) [3] => stdClass Object ( [id] => 123 [abstract_id] => 50 [vorname] => Oscar [name] => Chavez-Talavera [qualification] => [institution] => Universite Lille, Inserm [ort] => Lille [land] => FR [sort] => 2 [is_presenting_author] => [updated] => [created] => 0000-00-00 00:00:00 ) [4] => stdClass Object ( [id] => 124 [abstract_id] => 50 [vorname] => Anne [name] => Tailleux [qualification] => [institution] => Universite Lille, Inserm [ort] => Lille [land] => FR [sort] => 4 [is_presenting_author] => [updated] => [created] => 0000-00-00 00:00:00 ) [5] => stdClass Object ( [id] => 125 [abstract_id] => 50 [vorname] => Bart [name] => Staels [qualification] => [institution] => Universite Lille, Inserm [ort] => Lille [land] => FR [sort] => 9 [is_presenting_author] => [updated] => [created] => 0000-00-00 00:00:00 ) [6] => stdClass Object ( [id] => 126 [abstract_id] => 50 [vorname] => Arnold [name] => von Eckardstein [qualification] => [institution] => University of Zurich and University Hospital Zurich [ort] => Schlieren-Zurich [land] => [sort] => 8 [is_presenting_author] => [updated] => [created] => 0000-00-00 00:00:00 ) [7] => stdClass Object ( [id] => 127 [abstract_id] => 50 [vorname] => Christian [name] => Wolfrum [qualification] => [institution] => ETH Zurich-TNB [ort] => Schwerzenbach [land] => [sort] => 5 [is_presenting_author] => [updated] => [created] => 0000-00-00 00:00:00 ) [8] => stdClass Object ( [id] => 128 [abstract_id] => 50 [vorname] => Frank [name] => Ruschitzka [qualification] => [institution] => Heart Center- University Hospital Zurich [ort] => Zurich [land] => [sort] => 7 [is_presenting_author] => [updated] => [created] => 0000-00-00 00:00:00 ) [9] => stdClass Object ( [id] => 129 [abstract_id] => 50 [vorname] => Thomas [name] => Lutz [qualification] => [institution] => Veterinary Physiology-University of Zurich [ort] => Zurich [land] => [sort] => 6 [is_presenting_author] => [updated] => [created] => 0000-00-00 00:00:00 ) ) [files] => Array ( ) [main_author] => stdClass Object ( [id] => 121 [abstract_id] => 50 [vorname] => Anne [name] => Jomard [qualification] => [institution] => University of Zurich and University Hospital Zurich [ort] => Schlieren-Zurich [land] => [sort] => 1 [is_presenting_author] => [updated] => [created] => 0000-00-00 00:00:00 ) [formatted_contact] =>
Elena Osto
CH-8952 Schlieren-Zurich
elena.osto@uzh.ch ) [session] => stdClass Object ( [id] => 1 [name] => Poster [date] => 2019-05-09 [start] => 00:00:00 [end] => 00:00:00 [abbr] => P [updated] => [created] => 0000-00-00 00:00:00 ) [formatted_authors] => E. Osto1, A. Jomard1, P. Doytcheva1, O. Chavez-Talavera2, A. Tailleux2, B. Staels2, A. von Eckardstein1, C. Wolfrum3, F. Ruschitzka4, T. Lutz4 (1Schlieren-Zurich ; 2Lille FR; 3Schwerzenbach ; 4Zurich) [detail_url] => https://www.iscp2019.com/abstracts/presentation/14 )